|
1
|
Bentley R: From miso, sake and shoyu to
cosmetics: a century of science for kojic acid. Nat Prod Rep.
23:1046–1062. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Noh JM, Kwak SY, Kim DH, et al: Kojic
acid-tripeptide amide as a new tyrosinase inhibitor. Biopolymers.
88:300–307. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Aytemir MD and Özçelik B: A study of
cytotoxicity of novel chlorokojic acid derivatives with their
antimicrobial and antiviral activities. Eur J Med Chem.
45:4089–4095. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xiong X and Pirrung MC: Modular synthesis
of candidate indole-based insulin mimics by Claisen rearrangement.
Org Lett. 10:1151–1154. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kasser JH, Kandioller W, Hartinger CG, et
al: Mannich products of kojic acid and N-heterocycles and their
Ru(II) - arene complexes: synthesis, characterization and
stability. J Organomet Chem. 695:875–881. 2010. View Article : Google Scholar
|
|
6
|
Toy AD and Smith TD: Electron spin
resonance evidence for the existence of a dimeric form of the
copper (II) chelate of kojic acid. J Am Chem Soc. 93:3049–3050.
1971. View Article : Google Scholar
|
|
7
|
Yoo JY, Pradarelli J, Haseley A, et al:
Copper chelation enhances antitumor efficacy and systemic delivery
of oncolytic HSV. Clin Cancer Res. 18:4931–4941. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen YH, Lu PJ, Hulme C, et al: Synthesis
of kojic acid-derived copper-chelating apoptosis inducing agents.
Med Chem Res. 22:995–1003. 2013. View Article : Google Scholar
|
|
9
|
Fickova M, Pravodova E, Rondhal L, et al:
In vitro antiproliferative and cytotoxic activities of novel kojic
acid derivatives: 5-benzyloxy-2-selenocyanatomethyl- and
5-methoxy-2-selenocyanatomethyl-4-pyranone. J Appl Toxicol.
28:554–559. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yoo DS, Lee J, Choi SS, et al: A
modulatory effect of novel kojic acid derivatives on cancer cell
proliferation and macrophage activation. Pharmazie. 65:261–266.
2010.PubMed/NCBI
|
|
11
|
Hawtin RE, Stockett DE, Byl JAW, et al:
Voreloxin is an anticancer quinolone derivative that intercalates
DNA and poisons topoisomerase II. PLoS One. 5:e101862010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Seo KW, Holt R, Jung YS, et al:
Fluoroquinolone-mediated inhibition of cell growth, S-G2/M cell
cycle arrest, and apoptosis in canine osteosarcoma cell lines. PLoS
One. 7:e429602012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fu Y, Zhang Y, Zhou SF, et al: The effects
of substitution of carboxyl with hydrazide group on position 3 of
ciprofloxacin on its antimicrobial and antitumor activity. Int J
Pharmacol. 9:416–429. 2013. View Article : Google Scholar
|
|
14
|
Ahmed A and Daneshtalab M: Nonclassical
biological activities of quinolone derivatives. J Pharm Pharmaceut
Sci. 15:52–72. 2012.PubMed/NCBI
|
|
15
|
Yadav P and Joshi YC: Syntheses and
spectral studies of novel ciprofloxacin derivatives. Bull Chem Soc
Ethiop. 22:459–464. 2008.
|
|
16
|
Emami S, Ghafouri E, Faramarzi MA, et al:
Mannich bases of 7-piperazinylquinolones and kojic acid
derivatives: synthesis, in vitro antibacterial activity and in
silico study. Eur J Med Chem. 68:185–191. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jubie S, Sikdar P, Kalirajan R, et al:
Synthesis and antimicrobial activity of some novel ciprofloxacin
analogues. J Pharm Res. 3:511–513. 2010.
|
|
18
|
Alipour E, Mohammadhosseini N, Panah F, et
al: Synthesis and in vitro cytotoxic activity of
N-2-(2-Furyl)-2-(chlorobenzyloxyimino) ethyl ciprofloxacin
derivatives. E-J Chem. 8:1226–1231. 2011. View Article : Google Scholar
|
|
19
|
Cormiera R, Burdab WN, Harringtonb L, et
al: Studies on the antimicrobial properties of N-acylated
ciprofloxacins. Bioorg Med Chem Lett. 22:6513–6520. 2012.
View Article : Google Scholar
|
|
20
|
Bax BD, Chan PF, Eggleston DS, et al: Type
IIa topoisomerase inhibition by a new class of antibacterial
agents. Nature. 466:935–940. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ok K, Jung YW, Jee JG, et al: Facile
docking and scoring studies of carborane ligands with estrogen
receptor. Bull Korean Chem Soc. 34:1051–1054. 2013. View Article : Google Scholar
|
|
22
|
Trott O and Olson AJ: AutoDock Vina:
improving the speed and accuracy of docking with a new scoring
function, efficient optimization and multithreading. J Comput Chem.
31:455–461. 2010.PubMed/NCBI
|
|
23
|
Bourikas LA, Kolios G, Valatas V, et al:
Ciprofloxacin decreases survival in HT-29 cells via the induction
of TGF-β1 secretion and enhances the anti-proliferative effect of
5-fluorouracil. Br J Pharmacol. 157:362–370. 2009.PubMed/NCBI
|
|
24
|
Kwak SY, Choi HR, Park KC, et al: Kojic
acid-amino acid amide metal complexes and their melanogenesis
inhibitory activities. J Pept Sci. 17:791–797. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kwak SY, Noh JM, Park SH, et al: Enhanced
cell permeability of kojic acid-phenylalanine amide with metal
complex. Bioorg Med Chem Lett. 20:738–741. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kenyon GD, Chen Di, Shirley O, et al:
Clioquinol and pyrrolidine dithiocarbamate complex with copper to
form proteasome inhibitors and apoptosis inducers in human breast
cancer cells. Breast Cancer Res. 7:R897–R908. 2005. View Article : Google Scholar
|
|
27
|
Drlica K, Malik M, Kerns RJ and Zhao X:
Quinolone-mediated bacterial death. Antimicrob Agents Chemother.
52:385–392. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sun JP, Shi ZY, Liu SM, et al:
Trimethoxy-benzaldehyde levofloxacin hydrazone inducing the growth
arrest and apoptosis of human hepatocarcinoma cells. Cancer Cell
Int. 13:672013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ahmad M, Afzal M, Tabassum S, et al:
Synthesis and structure elucidation of a cobalt(II) complex as
topoisomerase I inhibitor: in vitro DNA binding, nuclease and RBC
hemolysis. Eur J Med Chem. 74:683–693. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kou JF, Qian C, Wang JQ, et al: Chiral
ruthenium(II) anthraquinone complexes as dual inhibitors of
topoisomerases I and II. J Biol Inorg Chem. 17:81–96. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Patel MN, Bhatt BS and Dosi PA:
Topoisomerase inhibition, nucleolytic and electrolytic contribution
on DNA binding activity exerted by biological active analogue of
coordination compounds. Appl Biochem Biotechnol. 166:1949–1968.
2012. View Article : Google Scholar
|
|
32
|
Castelli S, Vassallo O, Katkar P, et al:
Inhibition of human DNA topoisomerase IB by a cyclometalated gold
III compound: analysis on the different steps of the enzyme
catalytic cycle. Arch Biochem Biophys. 516:108–112. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang B: MetaPocket: a meta approach to
improve protein ligand binding site prediction. Omics. 13:325–330.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fukunishi Y and Nakamura H: Prediction of
ligand-binding sites of proteins by molecular docking calculation
for a random ligand library. Protein Sci. 20:95–106. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nikaido H and Pagès JM: Broad specificity
efflux pumps and their role in multidrug resistance of Gram
negative bacteria. FE MS Microbiol Rev. 36:340–363. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Takatsuka Y, Chen C and Nikaido H:
Mechanism of recognition of compounds of diverse structures by the
multidrug efflux pump AcrB of Escherichia coli. Proc Natl
Acad Sci USA. 107:6559–6565. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Singh S, Singh J, Gulia S, et al: Metal
ion selectivity of kojate complexes: a theoretical study. J Theor
Chem. 2013:3427832013. View Article : Google Scholar
|
|
38
|
Guo L, Liu XJ, Nishikawa K, et al:
Inhibition of topoisomerase IIA and G2 cell cycle arrest by NK314,
a novel benzo[c] phenanthridine currently in clinical trials. Mol
Cancer Ther. 6:1501–1508. 2007.PubMed/NCBI
|
|
39
|
Masamha CP and Benbrook DM: Cyclin D1
degradation is sufficient to induce G1 cell cycle arrest despite
constitutive expression of cyclin E2 in ovarian cancer cells.
Cancer Res. 69:6565–6572. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li TM, Chen GW, Su CC, et al: Ellagic acid
induced p53/p21 expression, G1 arrest and apoptosis in human
bladder cancer T24 cells. Anticancer Res. 25:971–980.
2005.PubMed/NCBI
|
|
41
|
Stravopodis DJ, Karkoulis PK, Konstantakou
EG, et al: Grade-dependent effects on cell cycle progression and
apoptosis in response to doxorubicin in human bladder cancer cell
lines. Int J Oncol. 34:137–160. 2009.PubMed/NCBI
|
|
42
|
Perry SW, Norman JP, Barbieri J, et al:
Mitochondrial membrane potential probes and the proton gradient: a
practical usage guide. Biotechniques. 50:98–115. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Rawi SM, Mourad IM, Arafa NMS, et al:
Effect of ciprofloxacin and levofloxacin on some oxidative stress
parameters in brain regions of male albino rats. Afr J Pharm
Pharmacol. 5:1888–1897. 2011.
|
